Horizon Pharma (HZNP) Tops Q2 EPS by 7c

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $172.8 million versus the consensus estimate of $156.41 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Chime to acquire Stride Bank for $590M in cash
• GameStop beats second quarter estimates on collectibles